Intelligent Breast Cancer Diagnosis System using Synergistic Combinations of DOT, AI, IoT, and Blockchain

A novel system integrating diffuse optical tomography (DOT) with AI, IoT, and blockchain technologies to provide accurate and personalized breast cancer diagnosis, risk assessment, and monitoring.

The original patent disclosed systems and methods for optimizing functional images of a lesion region using guided diffuse optical tomography. However, the existing technology has limitations in terms of accuracy, data security, and personalized diagnosis. The new inventive concept addresses these limitations by synergistically combining DOT with AI, IoT, and blockchain technologies to provide a more comprehensive and accurate breast cancer diagnosis system.

The system comprises a DOT device, an AI-powered processor, an IoT-enabled data transmission module, and a blockchain-based data storage system. The DOT device acquires lesion functional data and reference functional data from a healthy tissue region. The AI-powered processor analyzes the data using machine learning algorithms to detect vasculature distribution and assess tumor malignancy. The IoT-enabled module transmits the data to a cloud-based analytics platform, and the blockchain-based system securely stores the data. The system can be used for personalized breast cancer risk assessment, monitoring, and diagnosis. The AI-powered analytics engine can also detect anomalies indicative of breast cancer and generate a report.

The new inventive concept is novel and non-obvious in its synergistic combination of DOT, AI, IoT, and blockchain technologies to provide a more accurate and personalized breast cancer diagnosis system. The use of AI-powered processors, IoT-enabled data transmission, and blockchain-based data storage provides a unique and innovative approach to breast cancer diagnosis and monitoring.

Alternative embodiments of the system could include the use of different AI algorithms, IoT protocols, or blockchain architectures. The system could also be adapted for use in other medical imaging applications, such as detecting cardiovascular disease or monitoring diabetes.

The intelligent breast cancer diagnosis system has significant commercial potential in the medical imaging and healthcare industries. The system could be marketed to hospitals, clinics, and medical research institutions, and could also be used in personalized medicine and preventive care applications.